Welcome to our dedicated page for 3-D Sys Del news (Ticker: DDD), a resource for investors and traders seeking the latest updates and insights on 3-D Sys Del stock.
3D Systems Corporation (NYSE: DDD), a pioneer in additive manufacturing and digital dentistry solutions, provides investors and industry professionals with critical updates through this centralized news hub. Track official press releases, financial disclosures, and strategic developments from the company redefining 3D printing applications across healthcare, aerospace, and industrial manufacturing.
This resource offers timely access to earnings announcements, regulatory filings, and innovation milestones. Users will find updates on advanced manufacturing technologies like the Oqton Manufacturing OS, healthcare breakthroughs in patient-specific medical devices, and industrial applications of QuickCast Air investment casting solutions.
Key content categories include quarterly financial results, product launches, strategic partnerships, and regulatory compliance achievements. The curated collection serves as a reliable reference for assessing 3D Systems' market position and technological leadership in high-precision manufacturing.
Bookmark this page to stay informed about DDD's progress in materials science advancements, software platform enhancements, and global manufacturing initiatives. Check regularly for verified updates directly impacting investment decisions and industry analysis.
3D Systems (NYSE:DDD) has secured a $7.65 million contract from the U.S. Air Force for a Large-format Metal 3D Printer Advanced Technology Demonstrator (GEN-IIDMP-1000). The two-year contract extends an existing program focused on developing large-scale, high-speed flight-relevant additive manufacturing capabilities.
The work will be conducted at the company's facilities in San Diego, California and Rock Hill, South Carolina, with completion expected by September 27, 2027. This award builds on 3D Systems' ongoing collaboration with the U.S. Department of Defense since 2019, demonstrating innovative technologies for both large-scale systems and commercial printers.
3D Systems (NYSE:DDD) announced that CFO Jeffrey D. Creech will step down effective August 29, 2025, to pursue a new career opportunity. The company has appointed Phyllis Nordstrom, current Executive Vice President and Chief Administrative Officer, as Interim CFO.
Nordstrom, who joined 3D Systems in 2021, currently serves as Executive Vice President, Chief People Officer, and Chief Administrative Officer. She brings extensive experience in finance, accounting, and risk management from previous roles at MTS Systems Corporation, PricewaterhouseCoopers, Target, and U.S. Bank.
3D Systems (NYSE:DDD) reported Q2 2025 financial results with revenue of $94.8 million, down 16% year-over-year. The company posted a net income of $104.4 million, a significant improvement from a $27.3 million loss in Q2 2024. Healthcare Solutions revenue decreased 8% to $45.0 million, while Industrial Solutions fell 23% to $49.8 million.
Key highlights include double-digit growth in Medical Technology and Aerospace & Defense markets, with A&D revenues growing 84% year-over-year. The company's cost reduction initiatives resulted in over $20 million in operating expense savings. 3D Systems successfully restructured its balance sheet, retiring $88 million in debt and repurchasing 8 million shares. The company maintains $133.9 million in cash and restricted cash with total debt of $122.6 million as of June 30, 2025.
3D Systems (NYSE:DDD) has scheduled its second quarter 2025 financial results announcement for Monday, August 11, 2025, after market close. The company will host a conference call and webcast to discuss the results on Tuesday, August 12, 2025, at 8:30 a.m. Eastern Time.
Investors can access the conference call via telephone at 201-689-8345 or listen to the webcast through the company's investor relations website. A replay of the webcast will be available approximately two hours after the conference call concludes.
3D Systems (NYSE:DDD) has announced the full commercial release of its FDA-cleared NextDent® Jetted Denture Solution for the U.S. market. The groundbreaking solution features the new NextDent 300 MultiJet 3D printer and proprietary materials that enable single-piece, multi-material denture production with no post-curing requirements.
The solution delivers 300% faster production compared to traditional methods and 120% faster than existing resin printers. Key innovations include FDA-cleared NextDent® Jet Teeth and NextDent® Jet Base materials, offering superior aesthetics and breakage resistance. The U.S. dental replacement market is projected to reach $600 million by 2029, representing one-third of the global market opportunity.
Initial shipments are scheduled for August 2025, with European and Asian releases pending regulatory approvals. Beta testing has received strong endorsements from leading dental labs, highlighting significant improvements in efficiency, cost-effectiveness, and product quality.
3D Systems (NYSE:DDD) has achieved a significant milestone in regenerative medicine as its bioprinting technologies enabled FDA De Novo marketing authorization for a first-of-its-kind peripheral nerve repair solution. The company collaborated with French MedTech firm TISSIUM to develop COAPTIUM® CONNECT with TISSIUM Light, a bioabsorbable 3D-printed medical device utilizing unique photopolymer technology.
This breakthrough combines TISSIUM's biomorphic programmable polymers with 3D Systems' bioprinting expertise to create high-resolution, elastomeric biodegradable implants. The development builds on 3D Systems' nearly decade-long leadership in bioprinting, including its collaboration with United Therapeutics Corporation for human lung development. The global bioprinting market is projected to grow from $1.3 billion in 2024 to $2.4 billion by 2029.
3D Systems (NYSE:DDD) has announced significant balance sheet improvements through strategic financial transactions. The company has successfully retired $88 million of debt (41% of prior balance) at a discount to par value and refinanced with $92 million in new Convertible Senior Secured Notes due 2030. Additionally, DDD has repurchased 8 million shares (approximately 6% of outstanding common stock) to reduce dilution.
Following these transactions, DDD's balance sheet will include $35 million in existing notes due 2026, $92 million in new notes due 2030, and approximately $140 million in cash reserves. The new notes will bear interest at 5.875% per annum and are convertible at a 20% premium to the June 17, 2025 closing price.